Health Results-Based Financing Impact Evaluation 2013, Health Facility Baseline Survey
Burkina Faso, 2013 - 2014
Get Microdata
Reference ID
BFA_2013_HRBFIE-FBL_v01_M
Producer(s)
Paul Jacob Robyn, Aurelia Souares, Herve Hien
Collection(s)
Metadata
Created on
Jan 13, 2017
Last modified
Jan 17, 2017
Page views
124026
Downloads
9748
F6_221_Médicament acheté 5 (f6_221_5)
Data file: f6_aug19
Overview
Valid:
197
Invalid:
0
Type:
Discrete
Start:
1023
End:
1052
Width:
30
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 2 |
1%
|
|
| ACT 25MG | 1 |
0.5%
|
|
| ACT COMP | 1 |
0.5%
|
|
| ALBENDAZOLE | 4 |
2%
|
|
| ALBENDAZOLE COMP | 1 |
0.5%
|
|
| ALBENDAZOLE CP | 1 |
0.5%
|
|
| AMODIAQUINE ARTESUNATE | 1 |
0.5%
|
|
| AMOXI | 1 |
0.5%
|
|
| AMOXICILLINE | 3 |
1.5%
|
|
| AMOXICILLINE SUSPENSION | 1 |
0.5%
|
|
| AMPICILINE 1G | 1 |
0.5%
|
|
| AMPICILLINE INJ | 1 |
0.5%
|
|
| ANPI | 1 |
0.5%
|
|
| ARTESUNATE | 1 |
0.5%
|
|
| ARTESUNATE AMODIAQUINE | 1 |
0.5%
|
|
| ASAQ | 1 |
0.5%
|
|
| ASAQ SIROP | 1 |
0.5%
|
|
| ASL | 15 |
7.6%
|
|
| ASL 900MG INJECTABLE | 1 |
0.5%
|
|
| ASL INJ | 1 |
0.5%
|
|
| ASL INJECTABLE | 3 |
1.5%
|
|
| ASPEGIC | 1 |
0.5%
|
|
| BANDE | 1 |
0.5%
|
|
| CARBOCYSTEINE | 2 |
1%
|
|
| CARBOCYSTEINE 2% | 1 |
0.5%
|
|
| CARBOTOUX | 3 |
1.5%
|
|
| CARBOTOUX 2% SIROP | 1 |
0.5%
|
|
| CEFTRIOXONE | 1 |
0.5%
|
|
| CHLORPHENIRAMINE | 2 |
1%
|
|
| CHLORPHENIRAMINE 100MG | 1 |
0.5%
|
|
| CHLORPHENIRAMINE CP | 1 |
0.5%
|
|
| CLEXCULU | 1 |
0.5%
|
|
| COMPRESS | 1 |
0.5%
|
|
| COMPRESSES | 1 |
0.5%
|
|
| COPPI ASL | 1 |
0.5%
|
|
| COTRI | 1 |
0.5%
|
|
| COTRI 480 | 2 |
1%
|
|
| COTRI DIAZOPEN INJ | 1 |
0.5%
|
|
| COTRI SIROP | 1 |
0.5%
|
|
| COTRI SP | 1 |
0.5%
|
|
| COTRI SUP | 1 |
0.5%
|
|
| COTRIMOXAZOL CP | 1 |
0.5%
|
|
| COTRIMOXAZOLE | 7 |
3.6%
|
|
| COTRIMOXAZOLE COMP | 1 |
0.5%
|
|
| COTRIMOXAZOLE 480 MG CP | 1 |
0.5%
|
|
| DOUBA SIROP | 1 |
0.5%
|
|
| E PPI | 1 |
0.5%
|
|
| EAU POUR PREPARATION INJECTION | 1 |
0.5%
|
|
| EPPI | 3 |
1.5%
|
|
| EPPI 5ML | 1 |
0.5%
|
|
| ERY 250MG | 1 |
0.5%
|
|
| ERYTROMYCINE | 1 |
0.5%
|
|
| FER | 1 |
0.5%
|
|
| FER SIROP | 2 |
1%
|
|
| GANT | 1 |
0.5%
|
|
| GANTS | 1 |
0.5%
|
|
| GANTS D'EXAMEN | 1 |
0.5%
|
|
| GATENE | 1 |
0.5%
|
|
| GENTA | 1 |
0.5%
|
|
| GENTAMICINE | 1 |
0.5%
|
|
| HPV | 1 |
0.5%
|
|
| HYDROCORTISONE | 1 |
0.5%
|
|
| IBUPROFENE SIROP | 1 |
0.5%
|
|
| LUMARTEM | 1 |
0.5%
|
|
| LUMARTEM CP | 1 |
0.5%
|
|
| MEBENDAZOLE | 9 |
4.6%
|
|
| MEBENDAZOLE 100MG COMPRIME | 1 |
0.5%
|
|
| MEBENDAZOLE COMP | 1 |
0.5%
|
|
| MEBENDAZOLE CP | 6 |
3%
|
|
| MEBENDAZOLE SP | 1 |
0.5%
|
|
| METO | 2 |
1%
|
|
| METOCLOPRAMIDE | 4 |
2%
|
|
| METOCLOPRAMIDE INJ | 2 |
1%
|
|
| METOCLOPRAMIDE, DIAZEPAM | 1 |
0.5%
|
|
| METRONIDAZOLE CP | 2 |
1%
|
|
| MICONAZOLE POMMADE | 1 |
0.5%
|
|
| MULTIVITAMINE | 3 |
1.5%
|
|
| NYSTATIN | 1 |
0.5%
|
|
| NYSTATINE POMMADE | 1 |
0.5%
|
|
| NYSTATINE SUSP | 1 |
0.5%
|
|
| ORS | 1 |
0.5%
|
|
| PAN ASL | 1 |
0.5%
|
|
| PARACEMOL 500 | 1 |
0.5%
|
|
| PARACETAMOL | 7 |
3.6%
|
|
| PARACETAMOL CP 500MG | 1 |
0.5%
|
|
| PARACETAMOLE | 1 |
0.5%
|
|
| PHLOROGLUCINOL INJ | 1 |
0.5%
|
|
| QUININE | 3 |
1.5%
|
|
| QUININE 0,2 | 1 |
0.5%
|
|
| QUININE 0.20MG | 1 |
0.5%
|
|
| QUININE 02 | 1 |
0.5%
|
|
| QUININE 020 | 1 |
0.5%
|
|
| QUININE 200 | 1 |
0.5%
|
|
| QUININE 200MG INJECTABLE | 1 |
0.5%
|
|
| QUININE COMP | 1 |
0.5%
|
|
| QX 0,2 | 2 |
1%
|
|
| QX 020 | 1 |
0.5%
|
|
| QX 20 | 1 |
0.5%
|
|
| SERING | 2 |
1%
|
|
| SERINGUE | 7 |
3.6%
|
|
| SERINGUE 5CC | 2 |
1%
|
|
| SERINGUE SCC | 1 |
0.5%
|
|
| SERINGUE SRO | 1 |
0.5%
|
|
| SMECTA SACHES | 1 |
0.5%
|
|
| SPANODROP | 1 |
0.5%
|
|
| SPARADRAP | 1 |
0.5%
|
|
| SRO | 11 |
5.6%
|
|
| SULFATE DE ZINC | 2 |
1%
|
|
| THERMOMETRE | 1 |
0.5%
|
|
| VOGALENE INJ | 1 |
0.5%
|
|
| ZINC | 2 |
1%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.